nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CYP1A2—schizophrenia	0.256	0.431	CbGaD
Imatinib—CYP2D6—schizophrenia	0.198	0.332	CbGaD
Imatinib—ABCB1—schizophrenia	0.141	0.237	CbGaD
Imatinib—CA6—ear—schizophrenia	0.00657	0.0404	CbGeAlD
Imatinib—CA3—ear—schizophrenia	0.00622	0.0382	CbGeAlD
Imatinib—ABCA3—telencephalon—schizophrenia	0.00274	0.0169	CbGeAlD
Imatinib—DDR1—telencephalon—schizophrenia	0.00253	0.0156	CbGeAlD
Imatinib—NTRK1—midbrain—schizophrenia	0.00249	0.0153	CbGeAlD
Imatinib—Buclizine—CHRM1—schizophrenia	0.00245	0.41	CrCbGaD
Imatinib—HIPK4—gonad—schizophrenia	0.00232	0.0142	CbGeAlD
Imatinib—CYP2C19—urine—schizophrenia	0.00225	0.0138	CbGeAlD
Imatinib—CSF1R—blood plasma—schizophrenia	0.002	0.0123	CbGeAlD
Imatinib—ABCA3—blood—schizophrenia	0.002	0.0123	CbGeAlD
Imatinib—ABCA3—midbrain—schizophrenia	0.00197	0.0121	CbGeAlD
Imatinib—DDR1—blood—schizophrenia	0.00184	0.0113	CbGeAlD
Imatinib—CYP1A2—urine—schizophrenia	0.00184	0.0113	CbGeAlD
Imatinib—DDR1—midbrain—schizophrenia	0.00182	0.0112	CbGeAlD
Imatinib—KIT—blood plasma—schizophrenia	0.00182	0.0112	CbGeAlD
Imatinib—HIPK4—endocrine gland—schizophrenia	0.00175	0.0108	CbGeAlD
Imatinib—CYP2C9—urine—schizophrenia	0.00175	0.0107	CbGeAlD
Imatinib—CA1—blood plasma—schizophrenia	0.00166	0.0102	CbGeAlD
Imatinib—CA3—forebrain—schizophrenia	0.00162	0.00997	CbGeAlD
Imatinib—ABCA3—nervous system—schizophrenia	0.00162	0.00995	CbGeAlD
Imatinib—PIP4K2C—telencephalon—schizophrenia	0.00156	0.0096	CbGeAlD
Imatinib—ABCA3—central nervous system—schizophrenia	0.00156	0.00958	CbGeAlD
Imatinib—ABCA3—cerebellum—schizophrenia	0.00152	0.00936	CbGeAlD
Imatinib—CA3—telencephalon—schizophrenia	0.00149	0.00917	CbGeAlD
Imatinib—DDR1—cerebellum—schizophrenia	0.00141	0.00864	CbGeAlD
Imatinib—CA14—telencephalon—schizophrenia	0.00136	0.00832	CbGeAlD
Imatinib—CYP3A4—urine—schizophrenia	0.00133	0.00818	CbGeAlD
Imatinib—CYP2D6—urine—schizophrenia	0.00131	0.00805	CbGeAlD
Imatinib—PIP4K2C—gonad—schizophrenia	0.0013	0.00801	CbGeAlD
Imatinib—HIPK4—brain—schizophrenia	0.00125	0.00769	CbGeAlD
Imatinib—PDGFRA—forebrain—schizophrenia	0.00125	0.00765	CbGeAlD
Imatinib—ABCA3—brain—schizophrenia	0.00124	0.00761	CbGeAlD
Imatinib—ABL2—blood—schizophrenia	0.0012	0.00738	CbGeAlD
Imatinib—CYP2C19—blood plasma—schizophrenia	0.00118	0.00722	CbGeAlD
Imatinib—CA7—midbrain—schizophrenia	0.00117	0.00718	CbGeAlD
Imatinib—CA12—forebrain—schizophrenia	0.00115	0.00706	CbGeAlD
Imatinib—NQO2—telencephalon—schizophrenia	0.00115	0.00705	CbGeAlD
Imatinib—PDGFRA—telencephalon—schizophrenia	0.00115	0.00703	CbGeAlD
Imatinib—DDR1—brain—schizophrenia	0.00114	0.00702	CbGeAlD
Imatinib—PIP4K2C—blood—schizophrenia	0.00114	0.00698	CbGeAlD
Imatinib—Meclizine—CYP1A2—schizophrenia	0.00113	0.189	CrCbGaD
Imatinib—PIP4K2C—midbrain—schizophrenia	0.00112	0.00689	CbGeAlD
Imatinib—CSF1R—forebrain—schizophrenia	0.0011	0.00673	CbGeAlD
Imatinib—CA2—blood plasma—schizophrenia	0.00108	0.00662	CbGeAlD
Imatinib—CA12—telencephalon—schizophrenia	0.00106	0.00649	CbGeAlD
Imatinib—LCK—blood—schizophrenia	0.00101	0.0062	CbGeAlD
Imatinib—CSF1R—telencephalon—schizophrenia	0.00101	0.00619	CbGeAlD
Imatinib—PIP4K2C—endocrine gland—schizophrenia	0.000986	0.00606	CbGeAlD
Imatinib—CA14—midbrain—schizophrenia	0.000973	0.00598	CbGeAlD
Imatinib—CYP1A2—blood plasma—schizophrenia	0.00096	0.0059	CbGeAlD
Imatinib—PDGFRA—gonad—schizophrenia	0.000956	0.00587	CbGeAlD
Imatinib—CA3—endocrine gland—schizophrenia	0.000941	0.00578	CbGeAlD
Imatinib—CYP3A5—blood plasma—schizophrenia	0.000926	0.00569	CbGeAlD
Imatinib—PIP4K2C—nervous system—schizophrenia	0.000923	0.00567	CbGeAlD
Imatinib—ABL2—cerebellum—schizophrenia	0.000918	0.00564	CbGeAlD
Imatinib—KIT—telencephalon—schizophrenia	0.000915	0.00562	CbGeAlD
Imatinib—CYP2C9—blood plasma—schizophrenia	0.000911	0.0056	CbGeAlD
Imatinib—CA1—forebrain—schizophrenia	0.00091	0.00559	CbGeAlD
Imatinib—CA7—cerebellum—schizophrenia	0.000904	0.00555	CbGeAlD
Imatinib—CA9—endocrine gland—schizophrenia	0.000901	0.00554	CbGeAlD
Imatinib—PDGFRB—telencephalon—schizophrenia	0.000894	0.00549	CbGeAlD
Imatinib—PIP4K2C—central nervous system—schizophrenia	0.000888	0.00546	CbGeAlD
Imatinib—CA3—nervous system—schizophrenia	0.000881	0.00541	CbGeAlD
Imatinib—PIP4K2C—cerebellum—schizophrenia	0.000868	0.00533	CbGeAlD
Imatinib—CA3—central nervous system—schizophrenia	0.000848	0.00521	CbGeAlD
Imatinib—CSF1R—gonad—schizophrenia	0.000841	0.00517	CbGeAlD
Imatinib—CA1—telencephalon—schizophrenia	0.000837	0.00514	CbGeAlD
Imatinib—CYP3A7—endocrine gland—schizophrenia	0.000836	0.00514	CbGeAlD
Imatinib—SLC22A1—forebrain—schizophrenia	0.000835	0.00513	CbGeAlD
Imatinib—NQO2—blood—schizophrenia	0.000835	0.00513	CbGeAlD
Imatinib—PDGFRA—blood—schizophrenia	0.000833	0.00512	CbGeAlD
Imatinib—PTGS1—blood plasma—schizophrenia	0.000832	0.00511	CbGeAlD
Imatinib—NQO2—midbrain—schizophrenia	0.000824	0.00506	CbGeAlD
Imatinib—Ponatinib—CYP2D6—schizophrenia	0.000807	0.135	CrCbGaD
Imatinib—ABL1—telencephalon—schizophrenia	0.000797	0.0049	CbGeAlD
Imatinib—CA9—cerebellum—schizophrenia	0.000794	0.00488	CbGeAlD
Imatinib—SLC47A1—gonad—schizophrenia	0.000768	0.00472	CbGeAlD
Imatinib—SLC22A1—telencephalon—schizophrenia	0.000768	0.00472	CbGeAlD
Imatinib—KIT—gonad—schizophrenia	0.000764	0.00469	CbGeAlD
Imatinib—CA14—cerebellum—schizophrenia	0.000753	0.00462	CbGeAlD
Imatinib—PDGFRB—gonad—schizophrenia	0.000746	0.00458	CbGeAlD
Imatinib—ABL2—brain—schizophrenia	0.000745	0.00458	CbGeAlD
Imatinib—CA7—brain—schizophrenia	0.000734	0.00451	CbGeAlD
Imatinib—CSF1R—blood—schizophrenia	0.000733	0.0045	CbGeAlD
Imatinib—NQO2—endocrine gland—schizophrenia	0.000724	0.00445	CbGeAlD
Imatinib—CSF1R—midbrain—schizophrenia	0.000724	0.00445	CbGeAlD
Imatinib—PDGFRA—endocrine gland—schizophrenia	0.000722	0.00444	CbGeAlD
Imatinib—PIP4K2C—brain—schizophrenia	0.000705	0.00433	CbGeAlD
Imatinib—CYP3A4—blood plasma—schizophrenia	0.000695	0.00427	CbGeAlD
Imatinib—CYP2D6—blood plasma—schizophrenia	0.000684	0.0042	CbGeAlD
Imatinib—NQO2—nervous system—schizophrenia	0.000678	0.00416	CbGeAlD
Imatinib—PDGFRA—nervous system—schizophrenia	0.000676	0.00415	CbGeAlD
Imatinib—CA3—brain—schizophrenia	0.000673	0.00414	CbGeAlD
Imatinib—SLC47A1—blood—schizophrenia	0.00067	0.00411	CbGeAlD
Imatinib—CA12—endocrine gland—schizophrenia	0.000667	0.00409	CbGeAlD
Imatinib—KIT—blood—schizophrenia	0.000666	0.00409	CbGeAlD
Imatinib—ABL1—gonad—schizophrenia	0.000665	0.00409	CbGeAlD
Imatinib—KIT—midbrain—schizophrenia	0.000657	0.00404	CbGeAlD
Imatinib—NQO2—central nervous system—schizophrenia	0.000652	0.00401	CbGeAlD
Imatinib—PDGFRA—central nervous system—schizophrenia	0.000651	0.004	CbGeAlD
Imatinib—PDGFRB—blood—schizophrenia	0.00065	0.00399	CbGeAlD
Imatinib—PDGFRB—midbrain—schizophrenia	0.000642	0.00394	CbGeAlD
Imatinib—NQO2—cerebellum—schizophrenia	0.000638	0.00392	CbGeAlD
Imatinib—PDGFRA—cerebellum—schizophrenia	0.000636	0.00391	CbGeAlD
Imatinib—CSF1R—endocrine gland—schizophrenia	0.000636	0.00391	CbGeAlD
Imatinib—CA12—nervous system—schizophrenia	0.000624	0.00383	CbGeAlD
Imatinib—CA14—brain—schizophrenia	0.000612	0.00376	CbGeAlD
Imatinib—ORM1—blood—schizophrenia	0.00061	0.00375	CbGeAlD
Imatinib—CA1—blood—schizophrenia	0.000609	0.00374	CbGeAlD
Imatinib—CA12—central nervous system—schizophrenia	0.000601	0.00369	CbGeAlD
Imatinib—Nilotinib—CYP2D6—schizophrenia	0.000596	0.0994	CrCbGaD
Imatinib—CSF1R—nervous system—schizophrenia	0.000595	0.00366	CbGeAlD
Imatinib—CA2—forebrain—schizophrenia	0.00059	0.00362	CbGeAlD
Imatinib—SLC47A1—endocrine gland—schizophrenia	0.000581	0.00357	CbGeAlD
Imatinib—ABL1—blood—schizophrenia	0.000579	0.00356	CbGeAlD
Imatinib—KIT—endocrine gland—schizophrenia	0.000577	0.00355	CbGeAlD
Imatinib—Ponatinib—ABCB1—schizophrenia	0.000576	0.0962	CrCbGaD
Imatinib—CSF1R—central nervous system—schizophrenia	0.000573	0.00352	CbGeAlD
Imatinib—ABL1—midbrain—schizophrenia	0.000572	0.00352	CbGeAlD
Imatinib—PDGFRB—endocrine gland—schizophrenia	0.000564	0.00346	CbGeAlD
Imatinib—CSF1R—cerebellum—schizophrenia	0.00056	0.00344	CbGeAlD
Imatinib—SLC22A1—blood—schizophrenia	0.000559	0.00343	CbGeAlD
Imatinib—SLC47A1—nervous system—schizophrenia	0.000544	0.00334	CbGeAlD
Imatinib—CA2—telencephalon—schizophrenia	0.000543	0.00333	CbGeAlD
Imatinib—KIT—nervous system—schizophrenia	0.00054	0.00332	CbGeAlD
Imatinib—ORM1—endocrine gland—schizophrenia	0.000529	0.00325	CbGeAlD
Imatinib—CA1—endocrine gland—schizophrenia	0.000528	0.00324	CbGeAlD
Imatinib—PDGFRB—nervous system—schizophrenia	0.000528	0.00324	CbGeAlD
Imatinib—SLC47A1—central nervous system—schizophrenia	0.000523	0.00321	CbGeAlD
Imatinib—KIT—central nervous system—schizophrenia	0.00052	0.0032	CbGeAlD
Imatinib—NQO2—brain—schizophrenia	0.000518	0.00318	CbGeAlD
Imatinib—PDGFRA—brain—schizophrenia	0.000517	0.00317	CbGeAlD
Imatinib—SLC47A1—cerebellum—schizophrenia	0.000511	0.00314	CbGeAlD
Imatinib—KIT—cerebellum—schizophrenia	0.000509	0.00312	CbGeAlD
Imatinib—PDGFRB—central nervous system—schizophrenia	0.000508	0.00312	CbGeAlD
Imatinib—ABL1—endocrine gland—schizophrenia	0.000503	0.00309	CbGeAlD
Imatinib—ABCG2—telencephalon—schizophrenia	0.000503	0.00309	CbGeAlD
Imatinib—PDGFRB—cerebellum—schizophrenia	0.000497	0.00305	CbGeAlD
Imatinib—ORM1—nervous system—schizophrenia	0.000495	0.00304	CbGeAlD
Imatinib—CA1—nervous system—schizophrenia	0.000494	0.00304	CbGeAlD
Imatinib—ABCB1—blood plasma—schizophrenia	0.000492	0.00302	CbGeAlD
Imatinib—SLC22A1—endocrine gland—schizophrenia	0.000485	0.00298	CbGeAlD
Imatinib—CA12—brain—schizophrenia	0.000477	0.00293	CbGeAlD
Imatinib—ORM1—central nervous system—schizophrenia	0.000477	0.00293	CbGeAlD
Imatinib—CA1—central nervous system—schizophrenia	0.000476	0.00292	CbGeAlD
Imatinib—ABL1—nervous system—schizophrenia	0.00047	0.00289	CbGeAlD
Imatinib—PTGS1—forebrain—schizophrenia	0.000456	0.0028	CbGeAlD
Imatinib—CSF1R—brain—schizophrenia	0.000455	0.00279	CbGeAlD
Imatinib—SLC22A1—nervous system—schizophrenia	0.000454	0.00279	CbGeAlD
Imatinib—ABL1—central nervous system—schizophrenia	0.000453	0.00278	CbGeAlD
Imatinib—ABL1—cerebellum—schizophrenia	0.000443	0.00272	CbGeAlD
Imatinib—SLC22A1—central nervous system—schizophrenia	0.000437	0.00268	CbGeAlD
Imatinib—CYP2C19—blood—schizophrenia	0.000431	0.00265	CbGeAlD
Imatinib—Nilotinib—ABCB1—schizophrenia	0.000425	0.071	CrCbGaD
Imatinib—PTGS1—telencephalon—schizophrenia	0.000419	0.00257	CbGeAlD
Imatinib—SLC47A1—brain—schizophrenia	0.000415	0.00255	CbGeAlD
Imatinib—KIT—brain—schizophrenia	0.000413	0.00254	CbGeAlD
Imatinib—PDGFRB—brain—schizophrenia	0.000403	0.00248	CbGeAlD
Imatinib—CA2—blood—schizophrenia	0.000395	0.00242	CbGeAlD
Imatinib—CA2—midbrain—schizophrenia	0.00039	0.00239	CbGeAlD
Imatinib—CA1—brain—schizophrenia	0.000378	0.00232	CbGeAlD
Imatinib—CYP2D6—forebrain—schizophrenia	0.000375	0.0023	CbGeAlD
Imatinib—CYP2C19—endocrine gland—schizophrenia	0.000373	0.00229	CbGeAlD
Imatinib—ABCG2—blood—schizophrenia	0.000365	0.00224	CbGeAlD
Imatinib—ABCG2—midbrain—schizophrenia	0.000361	0.00222	CbGeAlD
Imatinib—ABL1—brain—schizophrenia	0.00036	0.00221	CbGeAlD
Imatinib—CYP1A2—blood—schizophrenia	0.000352	0.00216	CbGeAlD
Imatinib—SLC22A1—brain—schizophrenia	0.000347	0.00213	CbGeAlD
Imatinib—CYP2D6—telencephalon—schizophrenia	0.000344	0.00212	CbGeAlD
Imatinib—CA2—endocrine gland—schizophrenia	0.000342	0.0021	CbGeAlD
Imatinib—CYP3A5—blood—schizophrenia	0.000339	0.00208	CbGeAlD
Imatinib—CYP2C9—blood—schizophrenia	0.000334	0.00205	CbGeAlD
Imatinib—ALB—brain—schizophrenia	0.000332	0.00204	CbGeAlD
Imatinib—CA2—nervous system—schizophrenia	0.00032	0.00197	CbGeAlD
Imatinib—CA2—central nervous system—schizophrenia	0.000308	0.00189	CbGeAlD
Imatinib—CYP1A2—endocrine gland—schizophrenia	0.000305	0.00187	CbGeAlD
Imatinib—PTGS1—blood—schizophrenia	0.000305	0.00187	CbGeAlD
Imatinib—CA2—cerebellum—schizophrenia	0.000301	0.00185	CbGeAlD
Imatinib—CYP3A5—endocrine gland—schizophrenia	0.000294	0.00181	CbGeAlD
Imatinib—CYP2C9—endocrine gland—schizophrenia	0.00029	0.00178	CbGeAlD
Imatinib—ABCG2—cerebellum—schizophrenia	0.000279	0.00171	CbGeAlD
Imatinib—ABCB1—forebrain—schizophrenia	0.000269	0.00166	CbGeAlD
Imatinib—PTGS1—endocrine gland—schizophrenia	0.000264	0.00162	CbGeAlD
Imatinib—CYP3A4—blood—schizophrenia	0.000255	0.00156	CbGeAlD
Imatinib—CYP2D6—blood—schizophrenia	0.000251	0.00154	CbGeAlD
Imatinib—ABCB1—telencephalon—schizophrenia	0.000248	0.00152	CbGeAlD
Imatinib—PTGS1—nervous system—schizophrenia	0.000247	0.00152	CbGeAlD
Imatinib—CA2—brain—schizophrenia	0.000245	0.0015	CbGeAlD
Imatinib—PTGS1—central nervous system—schizophrenia	0.000238	0.00146	CbGeAlD
Imatinib—ABCG2—brain—schizophrenia	0.000227	0.00139	CbGeAlD
Imatinib—CYP3A4—endocrine gland—schizophrenia	0.000221	0.00136	CbGeAlD
Imatinib—CYP2D6—endocrine gland—schizophrenia	0.000217	0.00133	CbGeAlD
Imatinib—ABCB1—gonad—schizophrenia	0.000207	0.00127	CbGeAlD
Imatinib—CYP3A4—nervous system—schizophrenia	0.000207	0.00127	CbGeAlD
Imatinib—CYP2D6—nervous system—schizophrenia	0.000203	0.00125	CbGeAlD
Imatinib—CYP3A4—central nervous system—schizophrenia	0.000199	0.00122	CbGeAlD
Imatinib—CYP2D6—central nervous system—schizophrenia	0.000196	0.0012	CbGeAlD
Imatinib—CYP2D6—cerebellum—schizophrenia	0.000191	0.00118	CbGeAlD
Imatinib—PTGS1—brain—schizophrenia	0.000189	0.00116	CbGeAlD
Imatinib—ABCB1—blood—schizophrenia	0.00018	0.00111	CbGeAlD
Imatinib—ABCB1—midbrain—schizophrenia	0.000178	0.00109	CbGeAlD
Imatinib—ABCB1—endocrine gland—schizophrenia	0.000156	0.00096	CbGeAlD
Imatinib—CYP2D6—brain—schizophrenia	0.000155	0.000955	CbGeAlD
Imatinib—ABCB1—nervous system—schizophrenia	0.000146	0.000899	CbGeAlD
Imatinib—ABCB1—central nervous system—schizophrenia	0.000141	0.000865	CbGeAlD
Imatinib—ABCB1—cerebellum—schizophrenia	0.000138	0.000846	CbGeAlD
Imatinib—ABCB1—brain—schizophrenia	0.000112	0.000687	CbGeAlD
Imatinib—CYP2D6—Metabolism—CACNB2—schizophrenia	7.22e-06	3.05e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ERBB4—schizophrenia	7.21e-06	3.05e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—EP300—schizophrenia	7.18e-06	3.03e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CACNA1C—schizophrenia	7.18e-06	3.03e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TPH2—schizophrenia	7.16e-06	3.02e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CACNB2—schizophrenia	7.16e-06	3.02e-05	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—AKT1—schizophrenia	7.16e-06	3.02e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—DPYD—schizophrenia	7.1e-06	3e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—GSK3B—schizophrenia	7.06e-06	2.98e-05	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—AKT1—schizophrenia	7.05e-06	2.98e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—DPYD—schizophrenia	7.04e-06	2.97e-05	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—AKT1—schizophrenia	7.01e-06	2.96e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CACNA1C—schizophrenia	7.01e-06	2.96e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3C2A—schizophrenia	7e-06	2.96e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP2D6—schizophrenia	6.99e-06	2.95e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—SNAP25—schizophrenia	6.99e-06	2.95e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP26B1—schizophrenia	6.99e-06	2.95e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—APOE—schizophrenia	6.95e-06	2.94e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTHFR—schizophrenia	6.94e-06	2.93e-05	CbGpPWpGaD
Imatinib—LCK—Disease—GSK3B—schizophrenia	6.9e-06	2.91e-05	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—AKT1—schizophrenia	6.88e-06	2.91e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTHFR—schizophrenia	6.88e-06	2.91e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—APOA1—schizophrenia	6.87e-06	2.9e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTHFR—schizophrenia	6.87e-06	2.9e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL1B—schizophrenia	6.85e-06	2.89e-05	CbGpPWpGaD
Imatinib—CA12—Metabolism—AKT1—schizophrenia	6.83e-06	2.89e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3C2A—schizophrenia	6.83e-06	2.88e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EP300—schizophrenia	6.8e-06	2.87e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PLA2G4A—schizophrenia	6.78e-06	2.86e-05	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—AKT1—schizophrenia	6.77e-06	2.86e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—schizophrenia	6.71e-06	2.83e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—GSK3B—schizophrenia	6.68e-06	2.82e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL1B—schizophrenia	6.68e-06	2.82e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTHFR—schizophrenia	6.67e-06	2.82e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NRG1—schizophrenia	6.65e-06	2.81e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ESR1—schizophrenia	6.64e-06	2.8e-05	CbGpPWpGaD
Imatinib—KIT—Disease—EP300—schizophrenia	6.63e-06	2.8e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CACNA1C—schizophrenia	6.6e-06	2.79e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MEF2C—schizophrenia	6.59e-06	2.79e-05	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—AKT1—schizophrenia	6.57e-06	2.78e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CACNA1C—schizophrenia	6.55e-06	2.77e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	6.47e-06	2.73e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—APOE—schizophrenia	6.46e-06	2.73e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3C2A—schizophrenia	6.44e-06	2.72e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—APOE—schizophrenia	6.4e-06	2.71e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTHFR—schizophrenia	6.4e-06	2.7e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—APOE—schizophrenia	6.39e-06	2.7e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—APOA1—schizophrenia	6.39e-06	2.7e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3C2A—schizophrenia	6.38e-06	2.69e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—YWHAZ—schizophrenia	6.37e-06	2.69e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—AKT1—schizophrenia	6.36e-06	2.68e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EP300—schizophrenia	6.34e-06	2.68e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GAPDH—schizophrenia	6.33e-06	2.68e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—APOA1—schizophrenia	6.33e-06	2.67e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP1A2—schizophrenia	6.32e-06	2.67e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—APOA1—schizophrenia	6.32e-06	2.67e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EP300—schizophrenia	6.28e-06	2.65e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CLOCK—schizophrenia	6.28e-06	2.65e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SNAP25—schizophrenia	6.28e-06	2.65e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP2D6—schizophrenia	6.28e-06	2.65e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	6.26e-06	2.64e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ERBB3—schizophrenia	6.23e-06	2.63e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—TH—schizophrenia	6.23e-06	2.63e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GCLM—schizophrenia	6.23e-06	2.63e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TPH1—schizophrenia	6.23e-06	2.63e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—APOE—schizophrenia	6.21e-06	2.62e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—AKT1—schizophrenia	6.19e-06	2.62e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	6.19e-06	2.61e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—COMT—schizophrenia	6.15e-06	2.6e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—APOA1—schizophrenia	6.14e-06	2.59e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EP300—schizophrenia	6.13e-06	2.59e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP2D6—schizophrenia	6.13e-06	2.59e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SNAP25—schizophrenia	6.13e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GSTP1—schizophrenia	6.12e-06	2.59e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TPH2—schizophrenia	6.12e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CACNB2—schizophrenia	6.12e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MAOA—schizophrenia	6.11e-06	2.58e-05	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—AKT1—schizophrenia	6.1e-06	2.58e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—GSK3B—schizophrenia	6.02e-06	2.54e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—DPYD—schizophrenia	6.02e-06	2.54e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2A—schizophrenia	6e-06	2.53e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—EP300—schizophrenia	5.97e-06	2.52e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—APOE—schizophrenia	5.96e-06	2.52e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—APOA1—schizophrenia	5.89e-06	2.49e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PRKD1—schizophrenia	5.86e-06	2.47e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ABCB1—schizophrenia	5.8e-06	2.45e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SNAP25—schizophrenia	5.77e-06	2.44e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SNAP25—schizophrenia	5.72e-06	2.42e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP2D6—schizophrenia	5.72e-06	2.42e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP1A2—schizophrenia	5.68e-06	2.4e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—AKT1—schizophrenia	5.67e-06	2.39e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EP300—schizophrenia	5.66e-06	2.39e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GSTM1—schizophrenia	5.63e-06	2.38e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PLA2G4A—schizophrenia	5.63e-06	2.38e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—EP300—schizophrenia	5.6e-06	2.37e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CACNA1C—schizophrenia	5.59e-06	2.36e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TH—schizophrenia	5.59e-06	2.36e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APOE—schizophrenia	5.58e-06	2.36e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP1A2—schizophrenia	5.54e-06	2.34e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—APOA1—schizophrenia	5.51e-06	2.33e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL1B—schizophrenia	5.5e-06	2.32e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TH—schizophrenia	5.46e-06	2.31e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3C2A—schizophrenia	5.45e-06	2.3e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ESR1—schizophrenia	5.32e-06	2.25e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—COMT—schizophrenia	5.3e-06	2.24e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GSTP1—schizophrenia	5.27e-06	2.23e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MAOA—schizophrenia	5.26e-06	2.22e-05	CbGpPWpGaD
Imatinib—CA2—Metabolism—AKT1—schizophrenia	5.22e-06	2.21e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP1A2—schizophrenia	5.22e-06	2.2e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP1A2—schizophrenia	5.18e-06	2.19e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TH—schizophrenia	5.15e-06	2.17e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—EP300—schizophrenia	5.1e-06	2.15e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TH—schizophrenia	5.1e-06	2.15e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—AKT1—schizophrenia	5.1e-06	2.15e-05	CbGpPWpGaD
Imatinib—CA1—Metabolism—AKT1—schizophrenia	5.01e-06	2.12e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ABCB1—schizophrenia	4.99e-06	2.11e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTHFR—schizophrenia	4.97e-06	2.1e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—EP300—schizophrenia	4.92e-06	2.08e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—AKT1—schizophrenia	4.9e-06	2.07e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SNAP25—schizophrenia	4.89e-06	2.07e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP2D6—schizophrenia	4.89e-06	2.07e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GAPDH—schizophrenia	4.89e-06	2.06e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PLA2G4A—schizophrenia	4.85e-06	2.05e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—GSTM1—schizophrenia	4.85e-06	2.05e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CLOCK—schizophrenia	4.84e-06	2.05e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—GSK3B—schizophrenia	4.83e-06	2.04e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—COMT—schizophrenia	4.76e-06	2.01e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GSTP1—schizophrenia	4.73e-06	2e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MAOA—schizophrenia	4.72e-06	1.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TPH2—schizophrenia	4.72e-06	1.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CACNB2—schizophrenia	4.72e-06	1.99e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DPYD—schizophrenia	4.64e-06	1.96e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EP300—schizophrenia	4.64e-06	1.96e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—COMT—schizophrenia	4.64e-06	1.96e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APOE—schizophrenia	4.63e-06	1.96e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GSTP1—schizophrenia	4.62e-06	1.95e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MAOA—schizophrenia	4.61e-06	1.95e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.58e-06	1.93e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—APOA1—schizophrenia	4.58e-06	1.93e-05	CbGpPWpGaD
Imatinib—LCK—Disease—EP300—schizophrenia	4.54e-06	1.92e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—schizophrenia	4.54e-06	1.92e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCB1—schizophrenia	4.48e-06	1.89e-05	CbGpPWpGaD
Imatinib—CA9—Metabolism—AKT1—schizophrenia	4.4e-06	1.86e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EP300—schizophrenia	4.4e-06	1.86e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—COMT—schizophrenia	4.37e-06	1.85e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TH—schizophrenia	4.36e-06	1.84e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTP1—schizophrenia	4.35e-06	1.84e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GSTM1—schizophrenia	4.35e-06	1.84e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PLA2G4A—schizophrenia	4.35e-06	1.84e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MAOA—schizophrenia	4.34e-06	1.83e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—AKT1—schizophrenia	4.34e-06	1.83e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—COMT—schizophrenia	4.34e-06	1.83e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	4.32e-06	1.82e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTP1—schizophrenia	4.32e-06	1.82e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MAOA—schizophrenia	4.31e-06	1.82e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTHFR—schizophrenia	4.28e-06	1.81e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PLA2G4A—schizophrenia	4.25e-06	1.79e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GSTM1—schizophrenia	4.25e-06	1.79e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	4.21e-06	1.78e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	4.18e-06	1.76e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCB1—schizophrenia	4.12e-06	1.74e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—AKT1—schizophrenia	4.11e-06	1.74e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCB1—schizophrenia	4.09e-06	1.73e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—schizophrenia	4.01e-06	1.69e-05	CbGpPWpGaD
Imatinib—KIT—Disease—AKT1—schizophrenia	4.01e-06	1.69e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PLA2G4A—schizophrenia	4e-06	1.69e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTM1—schizophrenia	4e-06	1.69e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOE—schizophrenia	3.99e-06	1.68e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTM1—schizophrenia	3.97e-06	1.68e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PLA2G4A—schizophrenia	3.97e-06	1.68e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EP300—schizophrenia	3.96e-06	1.67e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOA1—schizophrenia	3.94e-06	1.66e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—schizophrenia	3.84e-06	1.62e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AKT1—schizophrenia	3.83e-06	1.62e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—AKT1—schizophrenia	3.79e-06	1.6e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SNAP25—schizophrenia	3.77e-06	1.59e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	3.77e-06	1.59e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—schizophrenia	3.75e-06	1.58e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—COMT—schizophrenia	3.71e-06	1.57e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—AKT1—schizophrenia	3.7e-06	1.56e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTP1—schizophrenia	3.69e-06	1.56e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—EP300—schizophrenia	3.68e-06	1.56e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MAOA—schizophrenia	3.68e-06	1.55e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—EP300—schizophrenia	3.65e-06	1.54e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—EP300—schizophrenia	3.64e-06	1.54e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—AKT1—schizophrenia	3.61e-06	1.52e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOE—schizophrenia	3.58e-06	1.51e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.57e-06	1.51e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOA1—schizophrenia	3.54e-06	1.49e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—EP300—schizophrenia	3.54e-06	1.49e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—schizophrenia	3.54e-06	1.49e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—schizophrenia	3.51e-06	1.48e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOE—schizophrenia	3.49e-06	1.48e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCB1—schizophrenia	3.49e-06	1.47e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOA1—schizophrenia	3.45e-06	1.46e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—AKT1—schizophrenia	3.42e-06	1.44e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	3.41e-06	1.44e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—EP300—schizophrenia	3.4e-06	1.43e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTM1—schizophrenia	3.39e-06	1.43e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PLA2G4A—schizophrenia	3.39e-06	1.43e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—AKT1—schizophrenia	3.39e-06	1.43e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TH—schizophrenia	3.36e-06	1.42e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—schizophrenia	3.32e-06	1.4e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOE—schizophrenia	3.29e-06	1.39e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOE—schizophrenia	3.26e-06	1.38e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOA1—schizophrenia	3.25e-06	1.37e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOA1—schizophrenia	3.23e-06	1.36e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EP300—schizophrenia	3.18e-06	1.34e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—schizophrenia	3.15e-06	1.33e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—schizophrenia	3e-06	1.27e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—AKT1—schizophrenia	2.97e-06	1.25e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—COMT—schizophrenia	2.86e-06	1.21e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTP1—schizophrenia	2.85e-06	1.2e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MAOA—schizophrenia	2.84e-06	1.2e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—schizophrenia	2.83e-06	1.2e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AKT1—schizophrenia	2.81e-06	1.19e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOE—schizophrenia	2.79e-06	1.18e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOA1—schizophrenia	2.76e-06	1.16e-05	CbGpPWpGaD
Imatinib—LCK—Disease—AKT1—schizophrenia	2.74e-06	1.16e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCB1—schizophrenia	2.69e-06	1.14e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AKT1—schizophrenia	2.66e-06	1.12e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—EP300—schizophrenia	2.64e-06	1.11e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	2.62e-06	1.1e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTM1—schizophrenia	2.62e-06	1.1e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AKT1—schizophrenia	2.39e-06	1.01e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—schizophrenia	2.31e-06	9.76e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—schizophrenia	2.27e-06	9.61e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—EP300—schizophrenia	2.27e-06	9.6e-06	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AKT1—schizophrenia	2.23e-06	9.4e-06	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AKT1—schizophrenia	2.21e-06	9.32e-06	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AKT1—schizophrenia	2.2e-06	9.3e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOE—schizophrenia	2.15e-06	9.09e-06	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AKT1—schizophrenia	2.14e-06	9.03e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOA1—schizophrenia	2.13e-06	8.99e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AKT1—schizophrenia	2.05e-06	8.67e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—EP300—schizophrenia	2.04e-06	8.62e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—EP300—schizophrenia	1.99e-06	8.41e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AKT1—schizophrenia	1.92e-06	8.11e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—EP300—schizophrenia	1.88e-06	7.92e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—EP300—schizophrenia	1.86e-06	7.86e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AKT1—schizophrenia	1.59e-06	6.73e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—EP300—schizophrenia	1.59e-06	6.71e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—AKT1—schizophrenia	1.37e-06	5.8e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AKT1—schizophrenia	1.23e-06	5.21e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—EP300—schizophrenia	1.23e-06	5.18e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AKT1—schizophrenia	1.2e-06	5.08e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AKT1—schizophrenia	1.13e-06	4.79e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AKT1—schizophrenia	1.12e-06	4.75e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AKT1—schizophrenia	9.6e-07	4.06e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AKT1—schizophrenia	7.41e-07	3.13e-06	CbGpPWpGaD
